In the IFN-β-treated CF, the co-culture between CF and neutrophils a reduced MMP9 activity respect unstimulated CF was observed (denoted as black bars# in the graph), and these effects was not modified by JAK inhibition with ruxolitinib. The gene discussed is IFNB1; the disease is cystic fibrosis.